These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3685573)

  • 1. [Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline].
    Giedke H; Heimann H; Rein W
    Rev Electroencephalogr Neurophysiol Clin; 1987 Sep; 17(3):279-87. PubMed ID: 3685573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.
    Giedke H; Gaertner H; Breyer-Pfaff U; Rein W; Axmann D
    Eur Arch Psychiatry Neurol Sci; 1986; 235(6):329-38. PubMed ID: 3527706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of levoprotiline and amitriptyline in endogenous depressions.
    Faltus F; Molcan J; Svestka J; Náhunek K; Mrna B; Zapletálek M; Krekule P; Janecková E; Koníková M; Pazdírek S
    Act Nerv Super (Praha); 1989 Dec; 31(4):279-80. PubMed ID: 2638109
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychophysiological aspects of depressive syndromes.
    Giedke H; Heimann H
    Pharmacopsychiatry; 1987 Sep; 20(5):177-80. PubMed ID: 3671485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M; Laakmann G; Dieterle D; Blaschke D
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical evoked potentials and clinical rating scales as measures of depressive illness.
    Ashton H; Golding JF; Marsh VR; Thompson JW; Hassanyeh F; Tyrer SP
    Psychol Med; 1988 May; 18(2):305-17. PubMed ID: 3399583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term treatment with oxaprotiline in patients with major depression.
    Katz RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):875-83. PubMed ID: 2813805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

  • 9. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous measurement of various antidepressants in the plasma of depressed patients by high performance liquid chromatography.
    Yufu N; Itoh M; Notomi A; Nakao H
    Folia Psychiatr Neurol Jpn; 1984; 38(1):57-64. PubMed ID: 6537393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative clinical study of the association of chlordiazepoxide-amitriptyline and maprotiline in patients suffering from depression with anxiety components].
    Tsaras G; Ambrus J
    Rev Med Suisse Romande; 1981 Jun; 101(6):483-6. PubMed ID: 7029696
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of amitriptyline and maprotiline in old depressed patients.
    Koncevoj VA; Andrusenko MP; Pjatnickij AN; Kolibás E; Korinkova V; Mayer A
    Act Nerv Super (Praha); 1989 Jun; 31(2):117-8. PubMed ID: 2800942
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical, pharmacologic and psychophysiologic studies for the optimization of drug therapy in depressive illnesses].
    Gaertner HJ; Giedke H; Breyer-Pfaff U
    Nervenarzt; 1984 Mar; 55(3):133-6. PubMed ID: 6717696
    [No Abstract]   [Full Text] [Related]  

  • 14. The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.
    Burch JE
    Psychopharmacology (Berl); 1983; 80(3):254-8. PubMed ID: 6412270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
    Lehmann LS; Bowden CL; Redmond FC; Stanton BC
    Psychopharmacology (Berl); 1982; 77(2):193-7. PubMed ID: 6812139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression.
    Rihmer Z; Arató M; György S; Révai K; Demeter E
    Pharmacopsychiatry; 1985 Sep; 18(5):306-8. PubMed ID: 4048265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of improvement under antidepressant treatment: a survival-analytical approach.
    Stassen HH; Delini-Stula A; Angst J
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):127-35. PubMed ID: 8364348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amitriptyline and hydroxylated metabolite plasma levels in depressed outpatients.
    Robinson DS; Cooper TB; Howard D; Corcella J; Albright D
    J Clin Psychopharmacol; 1985 Apr; 5(2):83-8. PubMed ID: 3988974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical test of noradrenergic involvement in the therapeutic mode of action of an experimental antidepressant.
    Katz RJ; Lott M; Landau P; Waldmeier P
    Biol Psychiatry; 1993 Feb; 33(4):261-6. PubMed ID: 8471679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.
    Cording-Tömmel C; von Zerssen D
    Pharmacopsychiatria; 1982 Nov; 15(6):197-204. PubMed ID: 7156183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.